Sonos: Tuned For A Turnaround, But It Sounds Better Than It Is - Hold

Q4 FY25 beats on sales and EBITDA, but margins and strategy durability look uncertain. Read here for a detailed analysis.

Trading Day: Out of the Greenland, into the red

Stocks, bonds and the dollar tumbled on Tuesday, as U.S. President Donald Trump's threat to reignite a trade war and sour ...
Le Lézard

Scribe Therapeutics Projected to Enter the Clinic in Mid-2026 with STX-1150, a PCSK9-targeting CRISPR Epigenetic Silencing Therapy for Durable LDL-C Reduction

Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...
Le Lézard

Tangoe and Kubex Partner to Deliver Advanced Cloud and Kubernetes Optimization Through Tangoe One Cloud

Tangoe, a leader in technology expense management solutions for more than two decades, today announced a new partnership with Kubex, a recognized innovator in Kubernetes, GPU and cloud optimization.

The No-Code AI Workflow To Reduce Managerial Load In 2026

If you're leading a team in 2026, use this easy AI workflow to halve your prep and post-meeting time, and boost your ...

Alstom S.A.: Alstom's third quarter 2025/26: Record orders, Reaching €100bn backlog, FY 2025/26 outlook confirmed

Outstanding commercial momentum driving backlog to above €100bn Order intake of €9.6 billion in Q3 and €20.0 billion in the first 9 monthsBook-to-bill ratio1 of 1.4 for the Group and 1.8 for Rolling ...